These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33526943)

  • 1. Gene-based therapies for neurodegenerative diseases.
    Sun J; Roy S
    Nat Neurosci; 2021 Mar; 24(3):297-311. PubMed ID: 33526943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
    Donde A; Wong PC; Chen LL
    Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile somatic gene transfer for modeling neurodegenerative diseases.
    Klein RL; Wang DB; King MA
    Neurotox Res; 2009 Oct; 16(3):329-42. PubMed ID: 19669852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for neurodegenerative diseases.
    O'Connor DM; Boulis NM
    Trends Mol Med; 2015 Aug; 21(8):504-12. PubMed ID: 26122838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases.
    Parambi DGT; Alharbi KS; Kumar R; Harilal S; Batiha GE; Cruz-Martins N; Magdy O; Musa A; Panda DS; Mathew B
    Mol Neurobiol; 2022 Jan; 59(1):191-233. PubMed ID: 34655056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
    Piguet F; Alves S; Cartier N
    Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
    Joshi CR; Labhasetwar V; Ghorpade A
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseases.
    Agustín-Pavón C; Isalan M
    Bioessays; 2014 Oct; 36(10):979-90. PubMed ID: 25100403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for gene therapy in inherited neurodegenerative diseases.
    Cardone M
    Curr Opin Neurol; 2007 Apr; 20(2):151-8. PubMed ID: 17351484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Role of Gene Therapy for Neurological Disorders.
    Puranik N; Yadav D; Chauhan PS; Kwak M; Jin JO
    Curr Gene Ther; 2021; 21(1):11-22. PubMed ID: 32940177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
    Kuruvilla J; Sasmita AO; Ling APK
    Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.
    Lim ST; Airavaara M; Harvey BK
    Pharmacol Res; 2010 Jan; 61(1):14-26. PubMed ID: 19840853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.
    Li D; McIntosh CS; Mastaglia FL; Wilton SD; Aung-Htut MT
    Transl Neurodegener; 2021 May; 10(1):16. PubMed ID: 34016162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for gene therapy of spinal muscular atrophy with onasemnogene abeparvovec-AVXS-101 : Consensus paper of the German representatives of the Society for Pediatric Neurology (GNP) and the German treatment centers with collaboration of the medical scientific advisory board of the German Society for Muscular Diseases (DGM)].
    Ziegler A; Wilichowski E; Schara U; Hahn A; Müller-Felber W; Johannsen J; von der Hagen M; von Moers A; Stoltenburg C; Saffari A; Walter MC; Husain RA; Pechmann A; Köhler C; Horber V; Schwartz O; Kirschner J
    Nervenarzt; 2020 Jun; 91(6):518-529. PubMed ID: 32394004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.
    Barazesh M; Mohammadi S; Bahrami Y; Mokarram P; Morowvat MH; Saidijam M; Karimipoor M; Kavousipour S; Vosoughi AR; Khanaki K
    Curr Gene Ther; 2021; 21(2):130-148. PubMed ID: 33319680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising Targets for the Treatment of Neurodegenerative Diseases.
    Budd Haeberlein SL; Harris TJ
    Clin Pharmacol Ther; 2015 Nov; 98(5):492-501. PubMed ID: 26250447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prospects of using the technology of genome editing for correction of neurodegenerative diseases.].
    Stepanichev MY
    Adv Gerontol; 2018; 31(6):892-903. PubMed ID: 30877819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.